Cargando…

Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018

INTRODUCTION: No information is available in Belgium on life expectancy adjusted for health-related quality of life (HRQoL). Quality-adjusted life expectancy (QALE) captures the multidimensionality of health by accounting for losses in mortality and HRQoL linked to physical, mental, and social impai...

Descripción completa

Detalles Bibliográficos
Autores principales: Scohy, Aline, Charafeddine, Rana, Van Wilder, Lisa, Van Oyen, Herman, De Smedt, Delphine, Devleesschauwer, Brecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758921/
https://www.ncbi.nlm.nih.gov/pubmed/36527095
http://dx.doi.org/10.1186/s13690-022-01011-0
_version_ 1784852141572096000
author Scohy, Aline
Charafeddine, Rana
Van Wilder, Lisa
Van Oyen, Herman
De Smedt, Delphine
Devleesschauwer, Brecht
author_facet Scohy, Aline
Charafeddine, Rana
Van Wilder, Lisa
Van Oyen, Herman
De Smedt, Delphine
Devleesschauwer, Brecht
author_sort Scohy, Aline
collection PubMed
description INTRODUCTION: No information is available in Belgium on life expectancy adjusted for health-related quality of life (HRQoL). Quality-adjusted life expectancy (QALE) captures the multidimensionality of health by accounting for losses in mortality and HRQoL linked to physical, mental, and social impairments. The objective of this study is to estimate for Belgium QALE, the changes in QALE between 2013 and 2018 and the contribution of mortality, HRQoL and its dimensions to this trend. METHODS: The Belgian Health Interview Survey (BHIS), a representative sample of the general population, included the EQ-5D-5L instrument in 2013 and 2018. The tool assesses HRQoL comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) using a 5-level severity scoring to define a large variety of health states. The Sullivan method was used to compute at different ages QALE by gender using mortality data from the Belgian statistical office and average EQ-5D scores from the BHIS. QALE was calculated for 2013 and 2018, and changes in QALE over time were decomposed into mortality and ill-health effect. RESULTS: In 2018, QALE at age 15 years (QALE(15)) was 56.3 years for women and 55.8 years for men, a decrease from 2013 by 0.7 year for women and a stagnation for men. In men, the decrease in mortality counterbalanced the decline in HRQoL. The decline in QALE in women is driven by a decrease in mortality rates that is too small to compensate for the substantial decline in HRQoL before the age of 50 years. In women at older ages, improvements in HRQoL are observed. In women, QALE(15) is decreasing due to an increase in pain/discomfort, anxiety/depression and problems in usual activities. In men at age 15, the pain/discomfort and anxiety/depression domains contributed to the stagnation. QALE(65) increased somewhat, due to an improvement in self-care and mobility for both genders, and usual activities and anxiety/depression in men only. CONCLUSION: The strength of QALE as member of the family of composite indicators, the health expectancies, is the multidimensional structure of the underlying health component, including both ill-health with different health domains as levels of severity. The ability to decompose differences in the health expectancy not only into a mortality and health component but also into the different health dimensions allows to better inform on general population health trends. Next, compared to other health expectancy indicators, QALE is more sensitive to changes at younger ages. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-022-01011-0.
format Online
Article
Text
id pubmed-9758921
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97589212022-12-18 Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018 Scohy, Aline Charafeddine, Rana Van Wilder, Lisa Van Oyen, Herman De Smedt, Delphine Devleesschauwer, Brecht Arch Public Health Research INTRODUCTION: No information is available in Belgium on life expectancy adjusted for health-related quality of life (HRQoL). Quality-adjusted life expectancy (QALE) captures the multidimensionality of health by accounting for losses in mortality and HRQoL linked to physical, mental, and social impairments. The objective of this study is to estimate for Belgium QALE, the changes in QALE between 2013 and 2018 and the contribution of mortality, HRQoL and its dimensions to this trend. METHODS: The Belgian Health Interview Survey (BHIS), a representative sample of the general population, included the EQ-5D-5L instrument in 2013 and 2018. The tool assesses HRQoL comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) using a 5-level severity scoring to define a large variety of health states. The Sullivan method was used to compute at different ages QALE by gender using mortality data from the Belgian statistical office and average EQ-5D scores from the BHIS. QALE was calculated for 2013 and 2018, and changes in QALE over time were decomposed into mortality and ill-health effect. RESULTS: In 2018, QALE at age 15 years (QALE(15)) was 56.3 years for women and 55.8 years for men, a decrease from 2013 by 0.7 year for women and a stagnation for men. In men, the decrease in mortality counterbalanced the decline in HRQoL. The decline in QALE in women is driven by a decrease in mortality rates that is too small to compensate for the substantial decline in HRQoL before the age of 50 years. In women at older ages, improvements in HRQoL are observed. In women, QALE(15) is decreasing due to an increase in pain/discomfort, anxiety/depression and problems in usual activities. In men at age 15, the pain/discomfort and anxiety/depression domains contributed to the stagnation. QALE(65) increased somewhat, due to an improvement in self-care and mobility for both genders, and usual activities and anxiety/depression in men only. CONCLUSION: The strength of QALE as member of the family of composite indicators, the health expectancies, is the multidimensional structure of the underlying health component, including both ill-health with different health domains as levels of severity. The ability to decompose differences in the health expectancy not only into a mortality and health component but also into the different health dimensions allows to better inform on general population health trends. Next, compared to other health expectancy indicators, QALE is more sensitive to changes at younger ages. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-022-01011-0. BioMed Central 2022-12-17 /pmc/articles/PMC9758921/ /pubmed/36527095 http://dx.doi.org/10.1186/s13690-022-01011-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Scohy, Aline
Charafeddine, Rana
Van Wilder, Lisa
Van Oyen, Herman
De Smedt, Delphine
Devleesschauwer, Brecht
Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
title Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
title_full Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
title_fullStr Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
title_full_unstemmed Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
title_short Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
title_sort changes in quality-adjusted life expectancy in belgium, 2013 and 2018
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758921/
https://www.ncbi.nlm.nih.gov/pubmed/36527095
http://dx.doi.org/10.1186/s13690-022-01011-0
work_keys_str_mv AT scohyaline changesinqualityadjustedlifeexpectancyinbelgium2013and2018
AT charafeddinerana changesinqualityadjustedlifeexpectancyinbelgium2013and2018
AT vanwilderlisa changesinqualityadjustedlifeexpectancyinbelgium2013and2018
AT vanoyenherman changesinqualityadjustedlifeexpectancyinbelgium2013and2018
AT desmedtdelphine changesinqualityadjustedlifeexpectancyinbelgium2013and2018
AT devleesschauwerbrecht changesinqualityadjustedlifeexpectancyinbelgium2013and2018